Q3 2013 · —
Revenue$213.25M$213.25M +1.5% vs Q3 2012+3.7% vs Q2 2013
Net Income-$30.33M-$30.33M N/M vs Q3 2012N/M vs Q2 2013
EPS Diluted-$1.09-$1.09 N/M vs Q3 2012N/M vs Q2 2013
Gross Profit$131,479,000+0.7%
Operating Income-$31,141,000N/M
Operating Cash Flowderived$30,808,000+10.4%
Free Cash Flowderived$17,561,000+114.4%
Margins · derived
Gross margin61.7%−0.5 pt vs Q3 2012
Operating margin-14.6%−24.0 pt vs Q3 2012
Net margin-14.2%−20.5 pt vs Q3 2012
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Revenue | $213.25M | $210.08M | $202.19M | $186.64M |
| Net Income | -$30.33M | $13.21M | $11.24M | $16.48M |
| EPS Diluted | -$1.09 | $0.46 | $0.39 | $0.55 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR